Inspyr Therapeutics (NSPX) Short Interest Ratio & Short Volume

Short interest is the volume of Inspyr Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 9,000 shares of NSPX short. Learn More on Inspyr Therapeutics' current short interest.

Inspyr Therapeutics saw a increase in short interest in September. As of September 15th, there was short interest totaling 9,000 shares, an increase of 8,900.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Inspyr Therapeutics: 180 Life Sciences Corp. (8.36%), Nexien BioPharma, Inc. (0.00%), NeuBase Therapeutics, Inc. (4.92%), GRI Bio, Inc. (1.81%), Comera Life Sciences Holdings, Inc. (2.38%), Aoxing Pharmaceutical Company, Inc. (0.00%), Panbela Therapeutics, Inc. (2.36%), InMed Pharmaceuticals Inc. (0.17%), PainReform Ltd. (1.21%), Biodexa Pharmaceuticals Plc (5.18%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Block, Inc. ($9.12 billion), S&P Global Inc. ($7.79 billion), Advanced Micro Devices, Inc. ($6.62 billion), Charter Communications, Inc. ($6.07 billion), Wayfair Inc. ($4.53 billion), Zoom Video Communications, Inc. ($3.45 billion), Uber Technologies, Inc. ($3.08 billion), Canadian Pacific Kansas City Limited ($2.97 billion), Palo Alto Networks, Inc. ($2.74 billion), and MongoDB, Inc. ($2.61 billion). View all of the most shorted stocks.

Short selling NSPX is an investing strategy that aims to generate trading profit from Inspyr Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Inspyr Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NSPX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NSPX, twice per month. The most recent reporting period available is September, 15 2021.